Clinical trials: Non-valvular Atrial Fibrillation (NVAF)
- Condition Non-valvular Atrial Fibrillation (NVAF)
- Funder type Industry (pharma, biotech, devices)
- Age group Children (under 18)
Atrial Fibrillation
Length of Stay in NVAF Patients Hospitalized and Initiated With Dabigatran or Warfarin in Japan
The primary objective of this study is to compare the Length of Stay from treatment of oral anticoagulant initiation to hospital discharge of patients hospitalized and subsequently treated with dabigatran or warfarin for…
- Trial name
- NCT02631057
- Testing
- Dabigatran, Warfarin
- Where
- 2 sites in Japan
- Volunteers
- 4,313 people
- Sponsor
- Boehringer Ingelheim